XML 43 R13.htm IDEA: XBRL DOCUMENT v3.19.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION

Stock Options and Awards

The Company’s equity incentive program is a long-term retention program that is intended to attract, retain, and provide incentives for employees, consultants, officers, and directors and to align stockholder and employee interests. The Company may grant time-based options, market condition-based options, stock appreciation rights, restricted stock ("RSA"), restricted stock units (“RSUs”), performance shares, performance units, and other stock-based to employees, officers, directors, and consultants. Under this program, stock options may be granted at prices not less than the fair market value on the date of grant for stock options. These stock options generally vest over four years and expire from seven to ten years from the grant date. In addition to time-based vesting, market condition-based options are subject to a market condition whereby the closing price of the Company common stock must exceed a certain level for a number of trading days within a specified time frame or the options will be canceled before the expiration of the options. RSAs generally vest over one year. RSUs generally vest over three years. Awards granted other than a stock option or stock appreciation right shall reduce the common stock shares available for grant by 1.75 shares for every share issued. On June 14, 2019, the Company's stockholders approved an increase to the number of common stock shares reserved for issuance by 2,595,751 shares.

A summary of the Company's equity incentive program is as follows (in thousands):

 
 
September 30,
2019
Common stock shares available for grant
 
3,172

Standard and market condition-based stock options outstanding
 
2,011

RSAs outstanding
 
91

RSUs outstanding
 
949



Time-Based Stock Options

The following summarizes activities for the time-based stock options for the nine months ended September 30, 2019 (in thousands except for weighted average exercise per share and weighted average remaining contractual life data):

 
 
Number of Shares
Underlying Stock Options
 
Weighted Average
Exercise Price
Per Share
 
Weighted Average
Remaining Contractual Life
(Years)
 
Aggregate
Intrinsic Value
Outstanding at December 31, 2018
 
1,862

 
$
9.44

 
2.85
 
$
751

Granted
 
783

 
$
8.25

 
 
 
 
Exercised
 
(173
)
 
$
7.16

 
 
 
 
Canceled or expired
 
(733
)
 
$
9.78

 
 
 
 
Outstanding as of September 30, 2019
 
1,739

 
$
8.98

 
3.35
 
$
128

Vested and expected to vest at September, 2019
 
1,739

 
$
8.98

 
3.35
 
$
128

Exercisable at September 30, 2019
 
927

 
$
9.57

 
0.52
 
$
10



Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the exercise price of the Company’s common stock for the options that were in-the-money.

Market Condition-Based Stock Options

In 2014, the Company began to grant market condition-based stock options. These stock options will vest if the closing price of the Company stock exceeds a certain level for a number of trading days within a specified time frame or the stock options will be canceled before the expiration of the stock options. As of September 30, 2019 and December 31, 2018, the Company had 272,081 market condition-based stock options outstanding. There were no market condition-based stock options granted, exercised or canceled during the nine months ended September 30, 2019.

Restricted Stock Units

The following summarizes RSU activities for the nine months ended September 30, 2019 (in thousands except for weighted average exercise per share and weighted average remaining contractual life data):

 
 
Number of Restricted Stock Units
 
Weighted Average Grant Date Fair Value
 
Weighted Average
Remaining Contractual Life
(Years)
 
Aggregate
Intrinsic Value
Outstanding at December 31, 2018
 
1,091

 
$
10.97

 
0.67
 
$
9,773

Granted
 
864

 
$
8.57

 

 


Released
 
(709
)
 
$
11.32

 

 


Forfeited
 
(297
)
 
$
9.84

 

 


Outstanding at September 30, 2019
 
949

 
$
8.88

 
1.47
 
$
7,259



Restricted Stock Awards

The following summarizes RSA activities for the nine months ended September 30, 2019 (in thousands except for weighted average exercise per share and weighted average remaining contractual life data):

 
 
Number of Restricted Stock Awards
 
Weighted Average Grant Date Fair Value
 
Weighted Average Remaining Recognition Period
(Years)
Outstanding at December 31, 2018
 
55

 
$
13.02

 
0.46
Granted
 
114

 
$
7.06

 
 
Released
 
(62
)
 
$
12.63

 
 
Forfeited
 
(16
)
 
$
7.27

 
 
Outstanding at September 30, 2019
 
91

 
$
7.45

 
0.70


Employee Stock Purchase Plan

Under the Company's 1999 Employee Stock Purchase Plan ("ESPP"), eligible employees may purchase common stock through payroll deductions at a purchase price of 85% of the lower of the fair market value of the Company’s common stock at the beginning of the offering period or the purchase date. Participants may not purchase more than 2,000 shares in a six months offering period or purchase stock having a value greater than $25,000 in any calendar year as measured at the beginning of the offering period. A total of 1.0 million shares of common stock has been reserved for issuance under the ESPP. During the nine months ended September 30, 2019, 21,741 shares were purchased under the ESPP. As of September 30, 2019, 253,437 shares were available for future purchase under the ESPP.

Stock-based Compensation Expense

The following table summarizes stock-based compensation expenses recognized for the three and nine months ended September 30, 2019 and 2018 (in thousands):

 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
Stock options
 
$
200

 
$
286

 
$
516

 
$
960

RSUs and RSAs
 
971

 
2,206

 
3,798

 
5,234

Employee stock purchase plan
 
16

 
22

 
57

 
72

Total
 
$
1,187

 
$
2,514

 
$
4,371

 
$
6,266

 
 
 
 
 
 
 
 
 
Sales and marketing
 
$
207

 
$
377

 
$
700

 
$
675

Research and development
 
234

 
561

 
1,054

 
1,382

General and administrative
 
746

 
1,576

 
2,617

 
4,209

Total
 
$
1,187

 
$
2,514

 
$
4,371

 
$
6,266



As of September 30, 2019, there was $9.3 million of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested stock options, RSAs and RSUs. This unrecognized compensation cost will be recognized over an estimated weighted-average period of approximately 2.78 years. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures.